Tumor control and cranial nerve outcomes after Gamma Knife radiosurgery for Glomus jugulare tumors: a systematic review, meta-analysis, and institutional failure pattern analysis
Purpose To define tumor control, cranial nerve toxicity, and progression patterns after Gamma Knife radiosurgery (GKRS) for glomus jugulare tumors using a systematic review/meta-analysis and an institutional cohort. Methods and Materials A PRISMA-compliant systematic review identified studies reporting outcomes of GKRS for glomus jugulare tumors. Random-effects meta-analyses of proportions were performed for radiographic tumor control, tumor shrinkage, new or worsened cranial nerve deficits, and hearing worsening using endpoint-specific denominators. Heterogeneity was quantified with I 2 . Sensitivity analyses excluding the institutional cohort were performed. The institutional jugulare subset contributed to pooled estimates, whereas the full institutional jugulotympanic cohort was analyzed descriptively for progression-free survival, failure pattern, and salvage. Results Twenty-six cohorts were included. Across 590 tumors, pooled radiographic tumor control after GKRS was 0.91 (95% CI, 0.88–0.94; I 2 = 0.0%). Across 518 tumors, pooled radiographic shrinkage was 0.51 (95% CI, 0.43–0.59; I 2 = 58.4%). Across 463 patients, pooled new or worsened cranial nerve deficit was 0.11 (95% CI, 0.08–0.14; I 2 = 0.0%). Hearing worsening was reported in a limited subset of 114 evaluable patients, with a pooled proportion of 0.16 (95% CI, 0.10–0.24; I 2 = 0.0%). Sensitivity analyses excluding the institutional cohort did not materially change pooled estimates. In the institutional cohort (n = 27), radiographic control at last follow-up was 85.2%. Kaplan–Meier PFS was 100.0% at 24 months and 77.8% at 60 months. Among 4 progression events, failures were predominantly marginal or out-of-field, with no clearly in-field failures; salvage GKRS was feasible in most recurrent cases. Conclusions GKRS provides durable tumor control with a favorable cranial nerve toxicity profile in glomus jugulare tumors. Treatment response is characterized more by stability than regression. In the institutional cohort, progression events were marginal or out-of-field rather than clearly in-field, supporting GKRS as an effective local-control strategy within the treated target while highlighting the importance of careful target delineation and long-term surveillance.
Authors
- Dheerendra Prasad (ORCID: https://orcid.org/0000-0002-6615-4235)
- Aditya Goyal (ORCID: https://orcid.org/0000-0002-5306-3166)
- Lindsay Lipinski (ORCID: https://orcid.org/0000-0002-1253-8516)
- Victor Goulenko (ORCID: https://orcid.org/0000-0001-9746-7931)
- Sarthak Sinha (ORCID: https://orcid.org/0000-0002-8084-3985)
- Neil D. Almeida (ORCID: https://orcid.org/0000-0002-7884-6394)
- Andrew J. Fabiano (ORCID: https://orcid.org/0000-0001-9991-6171)
- Venkatesh S. Madhugiri (ORCID: https://orcid.org/0000-0002-1517-9707)
- Rohan Kumar (ORCID: https://orcid.org/0000-0003-4477-211X)
- Rohil Shekher
- Robert A. Fenstermaker
- Kenneth V Snyder
Institutions
- Roswell Park Comprehensive Cancer Center (US)
- University at Buffalo, State University of New York (US)
Publication Details
- Journal
- Journal of Clinical Neuroscience
- Published
- 2026-07-01
- DOI
- https://doi.org/10.1016/j.jocn.2026.112173
- Primary Topic
- Adrenal and Paraganglionic Tumors
- Type
- article
- Field-Weighted Citation Impact
- 0.00